Cargando…
LRRK2 in Infection: Friend or Foe?
[Image: see text] In the field of Parkinson’s disease (PD) research, leucine-rich repeat kinase 2 (LRRK2) remains one of the most enigmatic kinases. LRRK2 pathogenic mutations result in increased kinase activity, making LRRK2 an attractive therapeutic target for PD. For over 10 years, the identifica...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical
Society
2019
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580364/ https://www.ncbi.nlm.nih.gov/pubmed/30915830 http://dx.doi.org/10.1021/acsinfecdis.9b00051 |